|
Tweet | ||
164 * ! | Mon, 8/10/2015, 10:30 AM - 12:20 PM | CC-3A | |
Subgroup Analyses: How Friendly Are They? — Topic Contributed Papers | |||
Biopharmaceutical Section , Section for Statistical Programmers and Analysts | |||
Organizer(s): Vipin Arora, Eli Lilly and Company | |||
Chair(s): Lisa LaVange, FDA/CDER | |||
10:35 AM | Subgroup Analysis: Issues in FDA-Reviewed Clinical Trials — Kathleen Fritsch, FDA | ||
10:55 AM | Visualization Tools for Subgroup Analysis: Are We Using Them to Their Optimal Capacity? — Vipin Arora, Eli Lilly and Company | ||
11:15 AM | Casting the Bones: The Worth and Potential Worthlessness of Subgroup Analyses — Kevin Buhr, University of Wisconsin - Madison | ||
11:35 AM | Subgroup Analysis Findings In Safety With No Statistical Power: What Do These Really Mean? — Melvin Munsaka, Takeda Development Center Americas, Inc. | ||
11:55 AM | Discussant: Judith Goldberg, New York University School of Medicine | ||
12:15 PM | Floor Discussion |
For program information, contact the JSM Registration Department or phone (888) 231-3473.
For Professional Development information, contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
2015 JSM Online Program Home
ASA Meetings Department
732 North Washington Street, Alexandria, VA 22314
(703) 684-1221 • meetings@amstat.org
Copyright © American Statistical Association.